These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32557953)

  • 1. HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway.
    Wang L; Gao Y; Zhao X; Guo C; Wang X; Yang Y; Han C; Zhao L; Qin Y; Liu L; Huang C; Wang W
    Cell Prolif; 2020 Aug; 53(8):e12835. PubMed ID: 32557953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor.
    Dong S; Ma X; Wang Z; Han B; Zou H; Wu Z; Zang Y; Zhuang L
    Oncotarget; 2017 Jun; 8(25):40583-40593. PubMed ID: 28489564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20.
    Wang L; Qiao C; Han L; Wang X; Miao J; Cao L; Huang C; Wang J
    Cell Death Dis; 2024 Mar; 15(3):221. PubMed ID: 38493218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
    Rong Z; Wang Z; Wang X; Qin C; Geng W
    J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.
    Wang L; Tong D; Guo Q; Wang X; Wu F; Li Q; Yang J; Zhao L; Qin Y; Liu Y; Huang C
    Sci Rep; 2018 Feb; 8(1):2431. PubMed ID: 29402992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-binding protein GRSF1 promotes hepatocarcinogenesis via competitively binding to YY1 mRNA with miR-30e-5p.
    Han L; Huang C; Wang X; Tong D
    J Exp Clin Cancer Res; 2022 Jan; 41(1):17. PubMed ID: 34998399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.
    Zhang L; Niu H; Ma J; Yuan BY; Chen YH; Zhuang Y; Chen GW; Zeng ZC; Xiang ZL
    Mol Cancer; 2019 Jul; 18(1):120. PubMed ID: 31349837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway.
    Wang L; Gao Y; Tong D; Wang X; Guo C; Guo B; Yang Y; Zhao L; Zhang J; Yang J; Qin Y; Liu L; Huang C
    Mol Oncol; 2021 Nov; 15(11):3147-3163. PubMed ID: 34028973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
    Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
    Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.
    Notarbartolo M; Giannitrapani L; Vivona N; Poma P; Labbozzetta M; Florena AM; Porcasi R; Muggeo VM; Sandonato L; Cervello M; Montalto G; D'Alessandro N
    OMICS; 2011 May; 15(5):267-72. PubMed ID: 21332389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
    Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
    Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma.
    Zhang D; Cao J; Zhong Q; Zeng L; Cai C; Lei L; Zhang W; Liu F
    Biomed Pharmacother; 2017 Nov; 95():1187-1193. PubMed ID: 28931210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
    Yang X; Liu L; Zou H; Zheng YW; Wang KP
    Dig Liver Dis; 2019 Oct; 51(10):1446-1455. PubMed ID: 31147216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.